Eugit Therapeutics

Eugit Therapeutics

Biotechnology Research

San Carlos, California 692 followers

Gamma delta T cell based immunotherapies

About us

Exploiting γδ T Cells for Diseases with Unmet Needs. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
San Carlos, California
Type
Privately Held
Founded
2022
Specialties
Immune system, Drug discovery, Immune-mediated diseases, Inflammatory Bowels Disease, IBD, and gamma delta T cells

Locations

Employees at Eugit Therapeutics

Similar pages

Funding

Eugit Therapeutics 1 total round

Last Round

Pre seed

US$ 500.0K

Investors

Y Combinator
See more info on crunchbase